Noctiva™ (desmopressin acetate) – New drug approval
March 3, 2017 – The FDA announced the approval of Serenity Pharmaceutical’s Noctiva (desmopressin acetate), for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void.
Download PDF
